0001465818-18-000010.txt : 20180202 0001465818-18-000010.hdr.sgml : 20180202 20180202115755 ACCESSION NUMBER: 0001465818-18-000010 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180202 DATE AS OF CHANGE: 20180202 EFFECTIVENESS DATE: 20180202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellular Biomedicine Group, Inc. CENTRAL INDEX KEY: 0001378624 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 861032927 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304709 FILM NUMBER: 18569409 BUSINESS ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: (408) 973-7884 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: EastBridge Investment Group Corp DATE OF NAME CHANGE: 20061019 D 1 primary_doc.xml X0708 D LIVE 0001378624 Cellular Biomedicine Group, Inc. 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA CALIFORNIA 95014 (408) 973-7884 DELAWARE EastBridge Investment Group Corp Corporation true Wen (Steve) Tao Liu 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Director Hansheng Zou 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Director Tony (Bizuo) Liu 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Executive Officer Chun Kwok Alan Au 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Director Gang Ji 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Director Terry A. Belmont 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Executive Officer Director Nadir Patel 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Director Yihong Yao 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Executive Officer Andrew Chan 19925 Stevens Creek Blvd. Suite 100 Cupertino CA CALIFORNIA 95014 Executive Officer Biotechnology Decline to Disclose 06b false 2018-01-30 false true false 0 30600000 30600000 0 false 3 0 0 30600000 Proceeds to be used for general corporate purposes which may include payments to executive officers. false Cellular Biomedicine Group, Inc. /s/ Andy Chan Andy Chan Secretary and Senior Vice President 2018-02-02